Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Transmedics Group Inc (TMDX)

Transmedics Group Inc (TMDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,903,972
  • Shares Outstanding, K 33,562
  • Annual Sales, $ 241,620 K
  • Annual Income, $ -25,030 K
  • EBIT $ 31 M
  • EBITDA $ 40 M
  • 60-Month Beta 2.12
  • Price/Sales 5.34
  • Price/Cash Flow 401.86
  • Price/Book 9.15

Options Overview Details

View History
  • Implied Volatility 74.23% ( +1.89%)
  • Historical Volatility 68.73%
  • IV Percentile 64%
  • IV Rank 36.65%
  • IV High 123.04% on 02/26/24
  • IV Low 46.00% on 08/16/24
  • Put/Call Vol Ratio 0.26
  • Today's Volume 4,999
  • Volume Avg (30-Day) 6,628
  • Put/Call OI Ratio 0.54
  • Today's Open Interest 40,395
  • Open Int (30-Day) 43,721

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate 0.18
  • Number of Estimates 6
  • High Estimate 0.25
  • Low Estimate 0.12
  • Prior Year 0.12
  • Growth Rate Est. (year over year) +50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.00 +12.67%
on 01/21/25
82.37 -24.77%
on 01/07/25
+0.27 (+0.44%)
since 12/20/24
3-Month
55.00 +12.67%
on 01/21/25
134.21 -53.83%
on 10/28/24
-60.97 (-49.59%)
since 10/22/24
52-Week
55.00 +12.67%
on 01/21/25
177.37 -65.06%
on 08/23/24
-26.14 (-29.67%)
since 01/22/24

Most Recent Stories

More News
Why TransMedics Fell 15.7% This Week

Shares of organ transplant innovator TransMedics Group (NASDAQ: TMDX) fell 15.7% through Thursday trading, according to data from S&P Global Market Intelligence .

TMDX : 61.97 (+9.24%)
TransMedics Stock Is Worth $0 According to This Short-Seller. Here's Why I'm Not Selling.

In this video, I will talk about TransMedics (NASDAQ: TMDX) and the recent short-seller report. Watch the short video to learn more, consider subscribing, and click the special offer link below.

TMDX : 61.97 (+9.24%)
Why TransMedics Group Stock Is Tanking Today

Shares of TransMedics Group (NASDAQ: TMDX) were tanking 14.3% lower as of 10:46 a.m. ET on Friday. The big sell-off came after activist short seller Scorpion Capital released a scathing report about TransMedics....

TMDX : 61.97 (+9.24%)
2 MedTech Stocks That Are Screaming Buys in January

At the intersection of healthcare and technology, medtech companies are leveraging innovative solutions to improve patient care and health outcomes. Industry leaders are well-positioned to deliver shareholder...

TMDX : 61.97 (+9.24%)
MDT : 87.84 (-0.61%)
Why Transmedics Plunged in December

Shares of Transmedics (NASDAQ: TMDX) fell 28.1% in December, according to data from S&P Global Market Intelligence .

TMDX : 61.97 (+9.24%)
1 Super Growth Stock Down 63% to Buy Hand Over Fist in 2025

Leading organ transplant technology provider TransMedics (NASDAQ: TMDX) increased sales by more than 100% in 10 straight quarters from early 2022 to mid-2024. However, after delivering revenue growth of...

TMDX : 61.97 (+9.24%)
"Rule Breaker Investing" Mailbag: Portfolio-Level Thinking

From a preschool teacher newly inspired to invest at 73 to a lifelong Fool whose Microsoft shares became a 500-bagger, this year-end mailbag edition brims with transformational stories.

NFLX : 953.99 (+9.69%)
META : 623.50 (+1.14%)
NVDA : 147.07 (+4.43%)
CSCO : 61.63 (+0.98%)
TMDX : 61.97 (+9.24%)
MSFT : 446.20 (+4.13%)
SHOP : 106.37 (+0.08%)
MELI : 1,818.49 (-0.87%)
TSLA : 415.11 (-2.11%)
SBUX : 97.73 (-0.26%)
WM : 211.44 (-0.70%)
MIDD : 143.72 (-0.05%)
TCMD Stock Rises 20% in Three Months: Should You Buy, Hold or Sell?

Tactile Systems Technology TCMD, a leader in innovative therapies for chronic conditions, has demonstrated consistent year-over-year revenue growth over the past three quarters. The company reported revenues...

TCMD : 17.38 (-2.08%)
ATOS : 0.9573 (+10.05%)
TMDX : 61.97 (+9.24%)
10 Overlooked Stocks Set to Soar in 2025

All 10 underperformed in 2024, but I believe they'll turn things around in 2025.

BABA : 86.40 (+1.19%)
ENPH : 60.99 (-2.94%)
CELH : 25.35 (-5.45%)
INTC : 21.86 (+0.41%)
AMD : 123.75 (+1.20%)
TMDX : 61.97 (+9.24%)
UBER : 67.82 (+0.12%)
PFE : 26.01 (-2.36%)
Is TransMedics Stock a Buy Before 2025?

In today's video, I will discuss recent updates about TransMedics (NASDAQ: TMDX) . Watch the short video to learn more, consider subscribing, and click the special offer link below.

TMDX : 61.97 (+9.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation....

See More

Key Turning Points

3rd Resistance Point 69.38
2nd Resistance Point 65.71
1st Resistance Point 63.84
Last Price 61.97
1st Support Level 58.30
2nd Support Level 54.63
3rd Support Level 52.76

See More

52-Week High 177.37
Fibonacci 61.8% 130.62
Fibonacci 50% 116.18
Fibonacci 38.2% 101.75
Last Price 61.97
52-Week Low 55.00

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar